The Moscow Arbitration Court has issued a new, expanded injunction order against VimpelCom that prevents the telecommunications company from paying dividends. The injunction is related to the Federal Anti-Monopoly Service’s claims against Telenor and Weather Investments, two of VimpelCom’s largest shareholders. The FAS alleges that Telenor bought preferred shares of VimpelCom from Weather in violation of the Russian Law on Strategic Investments.
In addidtion to the imposed ban on dividends, the following acts are prohibited by the injunction order:
– the transfer of the cash intended for dividend distribution to the accounts of OJSC VimpelCom or other companies with foreign banks;
– the external auditors elected at the OJSC VimpelCom AGM exercising the powers conferred on them;
– the board of directors of OJSC VimpelCom elected at the OJSC VimpelCom AGM exercising their powers pursuant to the charter of OJSC VimpelCom; and
– the taking of other actions and steps designated to transfer the indicated funds out of our Russian subsidiary OJSC VimpelCom.
Full content: MarketWatch
Related content: Competition Policy in Russia: Historical Sources, the Current State, and Evolutionary Perspectives (Yuri Rubin, Moscow University of Industry and Finance, Sovremennaya Konkurentsia & Denis Matvienko, Moscow University of Industry and Finance)
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Top Antitrust Expert Joins Cravath from Paul Weiss
Jan 21, 2025 by
CPI
CMA Chief Removed as UK Government Targets Regulatory Overhaul
Jan 21, 2025 by
CPI
Court Denies Dismissal in Crab Price-Fixing Lawsuit
Jan 21, 2025 by
CPI
TikTok Stays Online for Now: Trump Floats US Ownership Deal
Jan 21, 2025 by
CPI
Hong Kong Watchdog Unveils Compliance Tool for Small Businesses
Jan 21, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Pharmacy Benefit Managers
Jan 20, 2025 by
CPI
Untangling the PBM Mess
Jan 20, 2025 by
Kent Bernard
Using Data, Not Anecdotes, to Analyze Criticisms of Pharmacy Benefit Managers
Jan 20, 2025 by
Dennis Carlton
Vertical Integration and PBMs: What, Me Worry?
Jan 20, 2025 by
Lawton Robert Burns & Bradley Fluegel
The Economics of Benefit Management in Prescription-Drug Markets
Jan 20, 2025 by
Casey B. Mulligan